Medico Remedies Limited (BOM:540937)
India · Delayed Price · Currency is INR 42.11
-0.09 (-0.21%)
At close: Jun 16, 2026
Medico Remedies Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,064 | 1,509 | 1,449 | 1,404 | 1,210 |
Other Revenue | - | - | - | - | 0 |
| 2,064 | 1,509 | 1,449 | 1,404 | 1,210 | |
Revenue Growth (YoY) | 36.73% | 4.15% | 3.19% | 16.04% | -1.12% |
Cost of Revenue | 1,513 | 1,102 | 1,112 | 1,057 | 887.41 |
Gross Profit | 550.5 | 407.01 | 336.79 | 347.51 | 322.8 |
Selling, General & Admin | 73.98 | 63.63 | 59.68 | 57.91 | 60.09 |
Other Operating Expenses | 306.25 | 193.35 | 148.02 | 193.41 | 188.98 |
Operating Expenses | 411.17 | 287.28 | 236.49 | 278.52 | 271.25 |
Operating Income | 139.32 | 119.73 | 100.3 | 68.99 | 51.55 |
Interest Expense | -18.06 | -8.54 | -6.43 | -5.8 | -5.07 |
Interest & Investment Income | - | 1.05 | 0.94 | 1.01 | 0.7 |
Currency Exchange Gain (Loss) | - | 25.85 | 20.31 | 38.46 | 19.59 |
Other Non Operating Income (Expenses) | 59.34 | -3.04 | -1.81 | -1.67 | -1.56 |
EBT Excluding Unusual Items | 180.6 | 135.04 | 113.32 | 100.99 | 65.22 |
Gain (Loss) on Sale of Assets | - | - | 0.03 | - | -0.39 |
Pretax Income | 180.6 | 135.04 | 113.35 | 100.99 | 64.83 |
Income Tax Expense | 49.44 | 34.11 | 30.44 | 28.57 | 16.71 |
Net Income | 131.15 | 100.93 | 82.91 | 72.42 | 48.12 |
Net Income to Common | 131.15 | 100.93 | 82.91 | 72.42 | 48.12 |
Net Income Growth | 29.94% | 21.74% | 14.49% | 50.49% | 85.79% |
Shares Outstanding (Basic) | 83 | 83 | 83 | 83 | 83 |
Shares Outstanding (Diluted) | 83 | 83 | 83 | 83 | 83 |
Shares Change (YoY) | 0.03% | - | - | - | - |
EPS (Basic) | 1.58 | 1.22 | 1.00 | 0.87 | 0.58 |
EPS (Diluted) | 1.58 | 1.22 | 1.00 | 0.87 | 0.58 |
EPS Growth | 29.90% | 21.74% | 14.84% | 50.03% | 85.79% |
Free Cash Flow | 13.85 | 17.05 | -0.4 | 15.75 | -0.51 |
Free Cash Flow Per Share | 0.17 | 0.20 | -0.01 | 0.19 | -0.01 |
Gross Margin | 26.67% | 26.96% | 23.24% | 24.75% | 26.67% |
Operating Margin | 6.75% | 7.93% | 6.92% | 4.91% | 4.26% |
Profit Margin | 6.35% | 6.69% | 5.72% | 5.16% | 3.98% |
Free Cash Flow Margin | 0.67% | 1.13% | -0.03% | 1.12% | -0.04% |
EBITDA | 170.27 | 145.33 | 124.75 | 92.05 | 72.35 |
EBITDA Margin | 8.25% | 9.63% | 8.61% | 6.55% | 5.98% |
D&A For EBITDA | 30.95 | 25.61 | 24.45 | 23.05 | 20.8 |
EBIT | 139.32 | 119.73 | 100.3 | 68.99 | 51.55 |
EBIT Margin | 6.75% | 7.93% | 6.92% | 4.91% | 4.26% |
Effective Tax Rate | 27.38% | 25.26% | 26.86% | 28.29% | 25.77% |
Revenue as Reported | 2,123 | 1,536 | 1,470 | 1,444 | 1,231 |
Advertising Expenses | - | 0.86 | 0.47 | 0.37 | 5.66 |